EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non-Small-Cell Lung Cancer

被引:27
作者
Ackerman, Allison [1 ]
Goldstein, Michael A. [1 ]
Kobayashi, Susumu [1 ]
Costa, Daniel B. [1 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Hematol Oncol, Boston, MA 02215 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1097/JTO.0b013e3182635ab4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E19 / E20
页数:2
相关论文
共 6 条
[1]  
Gaughan Elizabeth M, 2011, Ther Adv Med Oncol, V3, P113, DOI 10.1177/1758834010397569
[2]   Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial [J].
Rosell, Rafael ;
Carcereny, Enric ;
Gervais, Radj ;
Vergnenegre, Alain ;
Massuti, Bartomeu ;
Felip, Enriqueta ;
Palmero, Ramon ;
Garcia-Gomez, Ramon ;
Pallares, Cinta ;
Miguel Sanchez, Jose ;
Porta, Rut ;
Cobo, Manuel ;
Garrido, Pilar ;
Longo, Flavia ;
Moran, Teresa ;
Insa, Amelia ;
De Marinis, Filippo ;
Corre, Romain ;
Bover, Isabel ;
Illiano, Alfonso ;
Dansin, Eric ;
de Castro, Javier ;
Milella, Michele ;
Reguart, Noemi ;
Altavilla, Giuseppe ;
Jimenez, Ulpiano ;
Provencio, Mariano ;
Angel Moreno, Miguel ;
Terrasa, Josefa ;
Munoz-Langa, Jose ;
Valdivia, Javier ;
Isla, Dolores ;
Domine, Manuel ;
Molinier, Olivier ;
Mazieres, Julien ;
Baize, Nathalie ;
Garcia-Campelo, Rosario ;
Robinet, Gilles ;
Rodriguez-Abreu, Delvys ;
Lopez-Vivanco, Guillermo ;
Gebbia, Vittorio ;
Ferrera-Delgado, Lioba ;
Bombaron, Pierre ;
Bernabe, Reyes ;
Bearz, Alessandra ;
Artal, Angel ;
Cortesi, Enrico ;
Rolfo, Christian ;
Sanchez-Ronco, Maria ;
Drozdowskyj, Ana .
LANCET ONCOLOGY, 2012, 13 (03) :239-246
[3]   Effectiveness of Tyrosine Kinase Inhibitors on "Uncommon" Epidermal Growth Factor Receptor Mutations of Unknown Clinical Significance in Non-Small Cell Lung Cancer [J].
Wu, Jenn-Yu ;
Yu, Chong-Jen ;
Chang, Yeun-Chung ;
Yang, Chih-Hsin ;
Shih, Jin-Yuan ;
Yang, Pan-Chyr .
CLINICAL CANCER RESEARCH, 2011, 17 (11) :3812-3821
[4]   Including Total EGFR Staining in Scoring Improves EGFR Mutations Detection by Mutation-Specific Antibodies and EGFR TKIs Response Prediction [J].
Wu, Shang-Gin ;
Chang, Yih-Leong ;
Lin, Jou-Wei ;
Wu, Chen-Tu ;
Chen, Hsuan-Yu ;
Tsai, Meng-Feng ;
Lee, Yung-Chie ;
Yu, Chong-Jen ;
Shih, Jin-Yuan .
PLOS ONE, 2011, 6 (08)
[5]   EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications [J].
Yasuda, Hiroyuki ;
Kobayashi, Susumu ;
Costa, Daniel B. .
LANCET ONCOLOGY, 2012, 13 (01) :E23-E31
[6]   Encouragement to Submit Data of Clinical Response to EGFR-TKIs in Patients With Uncommon EGFR Mutations [J].
Yatabe, Yasushi ;
Pao, William ;
Jett, James R. .
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (05) :775-776